Colorectal Carcinoma with Genetic Abnormalities

Colorectal Carcinoma with Genetic Abnormalities — Trials · CancerIndex

Clinical trials

Registered studies

31 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 11
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 27%
Top sponsor: Cancer Research UK
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06414304	Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy(BLOOMSI)	completed	—	30	OncoAtlas LLCINDUSTRY	1	Jun 27, 2025	clinicaltrials
NCT03263429	Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer	completed	Phase 1 / Phase 2	29	Vanderbilt-Ingram Cancer CenterOTHER	1